Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.3599
-0.0231 (-6.03%)
At close: Mar 4, 2026, 4:00 PM EST
0.3402
-0.0197 (-5.47%)
After-hours: Mar 4, 2026, 4:15 PM EST

Silo Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
3.923.913.5211.379.841.13
Short-Term Investments
2.023.174.1400.420
Cash & Short-Term Investments
5.947.087.6711.3710.261.13
Cash Growth
-25.91%-7.63%-32.58%10.85%808.83%831.59%
Other Receivables
---0.07-0.02
Total Trade Receivables
---0.07-0.02
Other Current Assets
0.230.030.020.140.150.27
Total Current Assets
6.167.117.6811.5710.41.43
Other Intangible Assets
0.220.24----
Other Long-Term Assets
0.220.360.130.070.09-
Total Assets
6.387.417.7511.6410.491.43
Accounts Payable
0.641.580.70.360.420.13
Current Portion of Long-Term Debt
-----0.01
Unearned Revenue
0.070.070.070.070.07-
Total Current Liabilities
0.711.660.780.440.490.14
Long-Term Debt
-----0
Other Long-Term Liabilities
0.670.720.790.870.94-
Total Long-Term Liabilities
0.670.720.790.870.940
Total Liabilities
1.382.381.571.31.430.15
Common Stock
000000.01
Treasury Stock
---0.47---
Additional Paid-in Capital
23.6120.317.5317.5112.327.03
Accumulated Other Comprehensive Income
0.010-0.01---
Retained Earnings
-18.61-15.26-10.87-7.17-3.26-5.76
Total Common Shareholders' Equity
5.015.036.1810.349.061.28
Shareholders' Equity
5.015.036.1810.349.061.28
Total Liabilities & Equity
6.387.417.7511.6410.491.43
Total Debt
-00000.02
Net Cash (Debt)
5.947.087.6711.3710.261.11
Net Cash Growth
-16.13%-7.63%-32.58%10.85%824.31%1772.23%
Net Cash Per Share
0.971.922.494.985.350.84
Book Value
5.015.036.1810.349.061.28
Book Value Per Share
0.811.372.014.534.720.97
Tangible Book Value
4.794.796.1810.349.061.28
Tangible Book Value Per Share
0.781.302.014.534.720.97
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q